Anti-IgLON5 disease is a relatively new neurological entity with the first cases reported in
2014. So far, less than 70 articles on this topic have been published. Due to its unspecific …

Background The objectives of this review and meta-analysis of polysomnographic data are
those to focus on the clinical use of clonazepam for the management of sleep disorders by …

Background Sleep behaviors are potentially modifiable risk factors for common mental
disorders and cardiovascular disease (CVD). However, the associations between combined …

Recurrent dream‐enactment behaviours (DEB) and rapid eye movement (REM) sleep
without atonia (RSWA) are two diagnostic hallmarks of REM sleep behaviour disorder …

Sleep parasomnias have drawn the interest of sleep experts because they represent a
valuable window to directly monitor dream activity and sleep mentation associated with …

Objective To investigate the risk factors for REM sleep behavior disorder (RBD) in a case-
control study. Methods Participants with probable RBD (pRBD) were defined using the RBD …

Purpose To review how REM sleep behavior disorder (RBD) is a complex condition with
heterogeneous underlying disorders; and to review clinical management issues and …

Background: The hypothesis of body-first vs. brain-first subtype of PD has been proposed
with REM-Sleep behavior disorder (RBD) defining the former. The body-first PD presumes …

Background and Objectives To evaluate the prevalence of REM sleep behavior disorder
(RBD) and its possible prodromal conditions, isolated dream enactment behavior (DEB) and …

REM sleep behavior disorder (RBD) is characterized by a loss of atonia of skeletal muscles
during REM sleep, associated with acting out behaviors during dreams. Knowledge of this …